2 February 2023
Aquis Exchange PLC
("Aquis" or the "Company")
Exercise of Share Options
and
Total Voting Rights
Aquis Exchange PLC (AQX.L), the exchange services group, announces that it has received notification that a former employee has exercised options under the Company's EMI Option Scheme over 7,333 ordinary shares of 10p each in the Company ("Ordinary Shares") at an exercise price of £3.47 per Ordinary Share.
Application has been made for 7,333 new Ordinary Shares to be admitted to trading on AQSE and AIM, which is expected to take place on 7 February 2023. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue.
Total Voting Rights
In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following this issue, its issued share capital will comprise 27,516,781 Ordinary Shares. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. Accordingly, the figure of 27,516,781 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Aquis Exchange PLC | Tel: +44 (0) 20 3597 6321 |
Alasdair Haynes, CEO |
|
Richard Fisher, CFO |
|
Adele Gilbert, Head of Marketing |
|
|
|
VSA Capital Limited (AQSE Corporate Adviser) | Tel: +44(0)20 3005 5000 |
Andrew Raca |
|
Tolgahan Kuce |
|
|
|
Liberum Capital Limited (Nominated Adviser and Joint Broker) | Tel: +44 (0) 20 3100 2000 |
Chris Clarke |
|
Clayton Bush |
|
Edward Thomas |
|
Kane Collings |
|
|
|
Canaccord Genuity Limited (Joint Broker) | Tel: +44 (0) 20 7523 8000 |
Emma Gabriel |
|
Patrick Dolaghan |
|
|
|
Alma PR (Financial PR Adviser) | Tel: +44 (0)20 3405 0209 |
Josh Royston | aquis@almapr.co.uk |
Kieran Breheny | |
Pippa Crabtree | |
Notes to Editors
About Aquis Exchange PLC
Aquis Exchange PLC ("Aquis") is a creator and facilitator of next-generation financial markets, through the provision of accessible, simple and efficient stock exchanges, trading venues and technology.
Aquis consists of three divisions: Aquis Exchange, a subscription-based exchange offering pan-European cash equities trading; Aquis Technologies, which develops and licenses next-generation exchange technology globally; and Aquis Stock Exchange, a growth and regulated primary exchange delivering capital to companies via the listing and trading of shares.
Aquis Exchange operates lit and dark order books, covering 16 European markets. For its lit books, Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis than other trading venues in Europe.
Aquis Technologies is the software and technology division of Aquis. It focuses on building better markets via the creation and licensing of cutting-edge, cost-effective exchange infrastructure technology and services, including matching engine and trade surveillance solutions.
Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.
Aquis is authorised and regulated by the UK Financial Conduct Authority and France's Autorité de contrôle prudentiel et de résolution and Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK/Switzerland and in EU27 respectively. Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu .
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.